New potentials for the correction of non-neoplastic melanin hyperpigmentation


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Hyperpigmentation is one of the most common reasons for seeking medical attention in aesthetic medicine. The main reasons for the formation of hyperpigmentation include primarily genetic, endocrine factors, and ultraviolet radiation, or their combination. Hyperpigmentation refers to aesthetic defects and can significantly reduce the quality of life of patients, especially when localized in open areas, which makes it relevant to study the effectiveness of new methods of therapy. Methods. The study included 36 patients with melasma, or post-inflammatory hyperpigmentation (PIH). All patients used Eucerin AntiPigment dermatocosmetics for 12 weeks. Efficacy was assessed using mexametry, IGA (Investigator’s Global Assessment) and DLQI (Dermatology Life Quality Index) clinical indices. Results. According to mexametry, all patients showed positive dynamics. The mexametry index decreased on average by 91.2% in patients with melasma and by 89.8% with PIH. The mean IGA and DLQI scores in patients with melasma decreased by 91.2 and 77.2% and in patients with PIH - by 89.8 and 74.3%. Conclusions. The use of Eucerin Anti-Pigment dermatocosmetics is effective in reducing hyperpigmentation and preventing its reappearance. Improvement is noted already after 2 weeks of use with further continuous improvement. The use of Eucerin Anti-Pigment is highly safe and well tolerated.

Full Text

Restricted Access

About the authors

Larisa S. Kruglova

Central State Medical Academy of Department of Presidential Affairs

Email: kruglovals@mail.ru
Dr. Sci (Med.), Professor, Vice-Rector for Academic Affairs, Head of the Department of Dermatovenereology and Cosmetology

M. A Avagumyan

Medical Research and Education Center of the Lomonosov Moscow State University (University Clinic)

References

  1. Потекаев Н.Н., Круглова Л.С. Гиперпигментация: причины возникновения и методы коррекции. Клиническая дерматология и венерология. 2012;10(6):65-70.
  2. Круглова Л.С., Стенько А.Г., Стрелкович Т. И. Этиология, патогенез, классификация и современные возможности лечения неопухолевых гиперпигментаций кожи. Пластическая хирургия и косметология. 2014;(1):105-10.
  3. Олисова О.Ю., Андреева Е.В. Еще раз о проблеме гиперпигментации. Российский журнал кожных и венерических болезней. 2014;2(17):20-4.
  4. Потекаев Н.Н., Круглова Л.С. Лазер в дерматологии и косметологии. М., 2012. 280 с.
  5. Круглова Л.С., Иконникова Е.В. Гиперпигментации кожи: современные взгляды на этиологию и патогенез. Российский журнал кожных и венерических болезней. 2017;20(3):178-83.
  6. Ibrahim Z.A., Gheida S.F., El Maghraby G.M., Farag I.E. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J. Cosmet Dermatol. 2015;14(2):113-23. doi: 10.1111/jocd.12143.
  7. Акне и розацеа. Под ред. Л.С. Кругловой. М., 2021. 207 с.
  8. Vashi N.A., Kundu R.V. Facial hyperpigmentation: causes and treatment. Br J. Dermatol. 2013;169(suppl. 3):41-56. Doi: 10.1111/ bjd.12536.
  9. Bang S.H., Han S.J., Kim D.H. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity J. Cosmet Dermatol. 2008;7(3):189-93. doi: 10.1111/j.1473-2165.2008.00387.x.
  10. Chaudhary S., Dayal S. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma. J. Drugs Dermatol. 2013;12(10):1149-53.
  11. Круглова Л.С., Стенько А.Г., Орлова Е.Н. Топическая терапия при коррекции очагов гипер пигментации. Клиническая дерматология и венерология. 2014;4:38-46.
  12. Mann T., Gerwat W., Batzer J., et al. inhibition of human tyro-sinase requires molecular motifs distinctively different frommushroom tyrosinase. J. invest Dermatol. 2018;138:1601-608. doi: 10.1016/j.jid.2018.01.019.
  13. Yang, P-C., Jafri M.S. Ca2+ signaling in T. lymphocytes: The interplay of the endoplasmic reticulum, mitochondria, membrane potential, and CRAC channels on transcription factor activation. Heliyon. 2020;6:e03526. Doi: 10.1016/j. heliyon.2020.e03526.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies